MarketPulse

licensing agreement

5 articles
BenzingaBenzinga··Bamboo Works

Jacobio Pharma Eyes 2026 Profitability on AstraZeneca Deal and Cancer Drug Sales

Chinese biotech Jacobio Pharmaceuticals expects profitability in 2026 via $100M AstraZeneca deal for KRAS inhibitor and growing Glecirasib sales.
AZNprofitabilitylicensing agreement
GlobeNewswire Inc.GlobeNewswire Inc.··Na

EssilorLuxottica Locks In D&G Through 2050 in Historic Eyewear Deal

EssilorLuxottica extends Dolce&Gabbana eyewear licensing deal through 2050, cementing a 46-year partnership with a major luxury fashion house.
ESLOYlicensing agreementpartnership extension
GlobeNewswire Inc.GlobeNewswire Inc.··Na

EssilorLuxottica Locks in D&G Through 2050 With Quarter-Century Extension

EssilorLuxottica extends Dolce&Gabbana eyewear licensing deal through 2050, securing 25-year partnership for frames design, production, and global distribution.
ESLOYlicensing agreementlong-term partnership
GlobeNewswire Inc.GlobeNewswire Inc.··Na

JAKKS Pacific Secures Major Anime Merchandise Deal with Crunchyroll

JAKKS Pacific partners with Crunchyroll to develop and distribute anime merchandise for five major franchises including My Hero Academia and Chainsaw Man across U.S. retail channels.
JAKKpartnershipanime merchandise
BenzingaBenzinga··Vandana Singh

Eli Lilly's Dual-Therapy Approach Demonstrates Enhanced Efficacy in Psoriasis-Obesity Treatment

Eli Lilly's combo therapy of Taltz and Zepbound showed superior results for psoriasis-obesity patients, achieving 27.1% complete skin clearance versus 5.8% for monotherapy.
LLYCSLLYPhase 3b trialZepbound